eniluracil has been researched along with Cancer of Gastrointestinal Tract in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Harper, P; Holford, C; Karapetis, C; Knight, S; Steer, C; Strickland, AH; Yip, D | 1 |
| Aboagye, EO; Brady, F; Jones, T; Lucas, SV; Osman, S; Price, PM; Saleem, A; Suttle, B; Yap, J | 1 |
| Aboagye, EO; Cunningham, VJ; Osman, S; Price, PM; Saleem, A | 1 |
1 trial(s) available for eniluracil and Cancer of Gastrointestinal Tract
| Article | Year |
|---|---|
Modulation of fluorouracil tissue pharmacokinetics by eniluracil: in-vivo imaging of drug action.
Topics: Administration, Oral; Adult; Aged; Antimetabolites, Antineoplastic; Dihydrouracil Dehydrogenase (NADP); Drug Interactions; Enzyme Inhibitors; Female; Fluorouracil; Gastrointestinal Neoplasms; Half-Life; Humans; Injections, Intravenous; Liver; Male; Middle Aged; Oxidoreductases; Tissue Distribution; Tomography, Emission-Computed; Uracil | 2000 |
2 other study(ies) available for eniluracil and Cancer of Gastrointestinal Tract
| Article | Year |
|---|---|
A dose-escalating study of oral eniluracil/5-fluorouracil plus oxaliplatin in patients with advanced gastrointestinal malignancies.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cohort Studies; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fluorouracil; Gastrointestinal Neoplasms; Humans; Male; Maximum Tolerated Dose; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Uracil | 2003 |
Extraction of 5-fluorouracil by tumor and liver: a noninvasive positron emission tomography study of patients with gastrointestinal cancer.
Topics: Antimetabolites, Antineoplastic; Dihydrouracil Dehydrogenase (NADP); Enzyme Inhibitors; Fluorine Radioisotopes; Fluorouracil; Gastrointestinal Neoplasms; Humans; Liver; Liver Neoplasms; Models, Biological; Oxidoreductases; Pancreatic Neoplasms; Tomography, Emission-Computed; Uracil | 2001 |